Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration

被引：0
|
作者：
Ranganayaki Muralidharan
Anish Babu
Narsireddy Amreddy
Kanthesh Basalingappa
Meghna Mehta
Allshine Chen
Yan Daniel Zhao
Uday B. Kompella
Anupama Munshi
Rajagopal Ramesh
机构：
[1] University of Oklahoma Health Sciences Center,Departments of Pathology
[2] University of Oklahoma Health Sciences Center,Departments of Radiation Oncology
[3] University of Oklahoma Health Sciences Center,Departments of Epidemiology and Statistics
[4] University of Oklahoma Health Sciences Center,Stephenson Cancer Center
[5] University of Oklahoma Health Sciences Center,Graduate Program in Biomedical Sciences
[6] University of Colorado,Department of Pharmaceutical Sciences and Opthalmology
[7] Stanton L. Young Biomedical Research Center,Department of Pathology
来源：
Journal of Nanobiotechnology | / 14卷
关键词：
Folate; HuR; Lung cancer; Nanoparticle; Oncoprotein; siRNA; Targeting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Epidermal growth factor receptor-targeted therapy and symptom improvement in non-small cell lung cancer
    Bonomi, PD
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (24) : S16 - S21
  • [32] Folate-targeted nanoparticle delivery of androgen receptor shRNA enhances the sensitivity of hormone-independent prostate cancer to radiotherapy
    Zhang, Xinjun
    Liu, Nianli
    Shao, ZhiYing
    Qiu, Hui
    Yao, Hong
    Ji, JiaYin
    Wang, Jianshe
    Lu, Wenchao
    Chen, Ronald C.
    Zhang, Longzhen
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (04) : 1309 - 1321
  • [33] RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells
    Zhao, L.
    Li, N.
    Yu, J. K.
    Tang, H. T.
    Li, Y. L.
    He, M.
    Yu, Z. J.
    Bai, X. F.
    Zheng, Z. H.
    Wang, E. H.
    Wei, M. J.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2014, 47 (01) : 24 - 34
  • [34] Targeted Disruption of HuR in Lung Cancer Cells Results in Global Knock-Down of HuR-Regulated Oncoproteins, Cell-Cycle Arrest and Reduced Cell Migration
    Muralidharan, Ranganayaki
    Babu, Anish
    Basalingappa, Kanthesh
    Munshi, Anupama
    Ramesh, Rajagopal
    MOLECULAR THERAPY, 2014, 22 : S44 - S44
  • [35] Efficient Delivery of Gemcitabine by Estrogen Receptor-Targeted PEGylated Liposome and Its Anti-Lung Cancer Activity In Vivo and In Vitro
    Tang, Huan
    Zhang, Zheng
    Zhu, Ming
    Xie, Yizhuo
    Lv, Zhe
    Liu, Rui
    Shen, Yujia
    Pei, Jin
    PHARMACEUTICS, 2023, 15 (03)
  • [36] miR-215 suppresses proliferation and migration of non-small cell lung cancer cells
    Cai, Xiaopan
    Peng, Dongyu
    Wei, Haifeng
    Yang, Xinghai
    Huang, Quan
    Lin, Zaijun
    Xu, Wei
    Qian, Ming
    Yang, Cheng
    Liu, Tielong
    Yan, Wangjun
    Zhao, Jian
    ONCOLOGY LETTERS, 2017, 13 (04) : 2349 - 2353
  • [37] Calponin 3 suppresses proliferation, migration and invasion of non-small cell lung cancer cells
    Yang, Chenglin
    Zhu, Shiping
    Feng, Weifeng
    Chen, Xuexin
    ONCOLOGY LETTERS, 2021, 22 (02)
  • [38] Phase I and PK Study of the Folate Receptor-Targeted Small Molecule Drug Conjugate (SMDC) EC1456 in Advanced Cancer: Lung Cancer Subset
    Edelman, Martin
    Sachdev, Jasgit
    Harb, Wael
    Armour, Allison
    Wang, Ding
    Garland, Linda
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1288 - S1289
  • [39] Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes
    Malhi, Sarandeep Singh
    Budhiraja, Abhishek
    Arora, Sumit
    Chaudhari, Kiran R.
    Nepali, Kunal
    Kumar, Raj
    Sohi, Harmik
    Murthy, Rayasa S. R.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 432 (1-2) : 63 - 74
  • [40] Non-small-cell lung cancer: clinical trial success influenced by biomarker- and receptor-targeted therapies
    Chamberlain, Dominic
    LUNG CANCER MANAGEMENT, 2014, 3 (02) : 128 - 128
12345